Genflow Biosciences plc (GENF.L)
GBp 1.53
(0.0%)
GBp 1.53
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.79 Million GBP | -34.67% |
| 2022 | -1.33 Million GBP | -35.09% |
| 2021 | -988.09 Thousand GBP | -90884.9% |
| 2020 | -1086.00 GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -815.07 Thousand GBP | -162.5% |
| 2023 Q1 | -310.49 Thousand GBP | 70.39% |
| 2023 FY | - GBP | -34.67% |
| 2023 Q4 | -982.46 Thousand GBP | -95.19% |
| 2023 Q3 | -503.33 Thousand GBP | 38.25% |
| 2022 Q2 | -773.48 Thousand GBP | -498919.35% |
| 2022 FY | - GBP | -35.09% |
| 2022 Q1 | -155.00 GBP | 0.0% |
| 2022 Q3 | -36.00 GBP | 100.0% |
| 2022 Q4 | -1.04 Million GBP | -2912733.33% |
| 2021 Q1 | - GBP | 0.0% |
| 2021 FY | - GBP | -90884.9% |
| 2021 Q2 | -263.97 Thousand GBP | 0.0% |
| 2020 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|